Xiaoyang Li
16PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Nov 11, 2025
Design, Synthesis, and Anti-inflammatory Activity Evaluation for Hydrazide-Based HDAC6 Targeted Protein Degraders.Simin Sun, Kairui Yue, Enqiang Liu
|Apr 07, 2025
Development of Hydrazide-Based HDAC6 Selective Inhibitors for Treating NLRP3 Inflammasome-Related Diseases.Kairui Yue, Simin Sun, Zequn Yin
|Jun 26, 2024
Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax.Wanting Hao, Leyan Wang, Tongqiang Xu
|Apr 26, 2024
An overview of sphingosine-1-phosphate receptor 2: Structure, biological function, and small-molecule modulators.Wanting Hao, Dongdong Luo, Yuqi Jiang
|Sep 11, 2023
Novel Sulfonylurea-Based NLRP3 Inflammasome Inhibitor for Efficient Treatment of Nonalcoholic Steatohepatitis, Endotoxic Shock, and Colitis.Zhuoyue Li, Yiming Chen, Xiaolin Jiang
|Sep 09, 2023
Discovery of a Novel Ubenimex Derivative as a First-in-Class Dual CD13/Proteasome Inhibitor for the Treatment of Cancer.Jian Zhang, Simin Sun, Jinyu Liu
Pageof 3
